Novartis AG (0QLR.IL)
IOB - IOB Delayed price. Currency in CHF
Add to watchlist
At close: 04:19PM BST
| Previous close | 75.83 |
| Open | 75.24 |
| Bid | 73.50 x N/A |
| Ask | 77.26 x N/A |
| Day's range | 75.17 - 75.91 |
| 52-week range | 72.84 - 89.28 |
| Volume | |
| Avg. volume | 1,107,006 |
| Market cap | 163.681B |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | 7.40 |
| EPS (TTM) | 10.18 |
| Earnings date | N/A |
| Forward dividend & yield | 3.10 (4.04%) |
| Ex-dividend date | 08 Mar 2022 |
| 1y target est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Novartis, Lowe's, The Goldman Sachs, Twitter and Xcel Energy
Novartis, Lowe's, The Goldman Sachs, Twitter and Xcel Energy are part of the Zacks top Analyst Blog.
- Zacks
Top Research Reports for Novartis, Lowe's & Goldman Sachs
Today's Research Daily features new research reports on 12 major stocks, including Novartis AG (NVS), Lowe's Companies, Inc. (LOW) and The Goldman Sachs Group, Inc. (GS).
- Zacks
GSK's (GSK) PD-1 Inhibitor Drug Meets Lung Cancer Study Goal
GSK's (GSK) mid-stage study, evaluating the combination of its cancer drug Jemperli with chemotherapy in non-small cell lung cancer, meets the primary endpoint of objective response rate.
© 2022 Yahoo. All rights reserved.
